The findings mean that for those using preexposure prophylaxis with gender-affirming hormone therapy or long-acting hormonal contraceptives, no dose adjustments need to be made to either medication.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/lenacapavir-prep-has-no-meaningful-interactions-hormonal-2025a1000ugx?src=rss
Author :
Publish date : 2025-11-05 11:55:00
Copyright for syndicated content belongs to the linked Source.
